Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-33822

Single-particle
3.3 Å
EMD-33822 Deposition: 13/07/2022
Map released: 19/07/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-33822

SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)

EMD-33822

Single-particle
3.3 Å
EMD-33822 Deposition: 13/07/2022
Map released: 19/07/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with NIV-8
Fitted models: 7yh7

Deposition Authors: Moriyama S , Anraku Y , Muranishi S, Adachi Y, Kuroda D , Higuchi Y, Kotaki R , Tonouchi K, Yumoto K , Suzuki T, Kita S , Someya T, Fukuhara H , Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K , Nakamura-Uchiyama F, Hashiguchi T , Hoshino A , Maenaka K, Takahashi Y
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
PUBMED: 37452031
DOI: doi:10.1038/s41467-023-39890-8
ISSN: 2041-1723